Emma J. Scott

Newcastle Upon Tyne, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

A xeno-free human iPSC-derived prostate organoid platform for multilineage differentiation and genetic manipulation.

A xeno-free human iPSC-derived prostate organoid platform for multilineage differentiation and genetic manipulation.

Journal: Cell reports methods

Published: May 05, 2026

Tissue-specific factors that govern the sialoglycan-Siglec axis in cancer.

Tissue-specific factors that govern the sialoglycan-Siglec axis in cancer.

Journal: Bioscience reports

Published: October 23, 2025

A general and accessible approach to enrichment and characterisation of natural anti-Neu5Gc antibodies from human samples.

A general and accessible approach to enrichment and characterisation of natural anti-Neu5Gc antibodies from human samples.

Journal: RSC chemical biology

Published: March 25, 2025

FUT8 Is a Critical Driver of Prostate Tumour Growth and Can Be Targeted Using Fucosylation Inhibitors.

FUT8 Is a Critical Driver of Prostate Tumour Growth and Can Be Targeted Using Fucosylation Inhibitors.

Journal: Cancer medicine

Published: February 13, 2025

A systematic review reveals conflicting evidence for the prevalence of antibodies against the sialic acid 'xenoautoantigen' Neu5Gc in humans and the need for a standardised approach to quantification.

A systematic review reveals conflicting evidence for the prevalence of antibodies against the sialic acid 'xenoautoantigen' Neu5Gc in humans and the need for a standardised approach to quantification.

Journal: Frontiers in molecular biosciences

Published: February 23, 2024

An ultra-conserved poison exon in the Tra2b gene encoding a splicing activator is essential for male fertility and meiotic cell division.

An ultra-conserved poison exon in the Tra2b gene encoding a splicing activator is essential for male fertility and meiotic cell division.

Journal: The EMBO journal

Published: November 22, 2023

Sialic acid blockade inhibits the metastatic spread of prostate cancer to bone.

Sialic acid blockade inhibits the metastatic spread of prostate cancer to bone.

Journal: EBioMedicine

Published: July 07, 2023

Epithelial specific splicing regulator proteins as emerging oncogenes in aggressive prostate cancer.

Epithelial specific splicing regulator proteins as emerging oncogenes in aggressive prostate cancer.

Journal: Oncogene

Published: July 07, 2023

CDC20 Is Regulated by the Histone Methyltransferase, KMT5A, in Castration-Resistant Prostate Cancer.

CDC20 Is Regulated by the Histone Methyltransferase, KMT5A, in Castration-Resistant Prostate Cancer.

Journal: Cancers

Published: May 26, 2023

ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer.

ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer.

Journal: Communications biology

Published: April 11, 2023

Engineering prostate cancer in vitro: what does it take?

Engineering prostate cancer in vitro: what does it take?

Journal: Oncogene

Published: March 30, 2023

ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression.

ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression.

Journal: The Journal of pathology

Published: February 28, 2023

Showing 1-12 of 28

Last Updated: 09/26/2026